Peptide-Targeted Polyplexes for Aerosol-Mediated Gene Delivery to CD49f-Overexpressing Tumor Lesions in Lung

Abstract

Peptide ligands can enhance delivery of nucleic acid-loaded nanoparticles to tumors by promoting their cell binding and internalization. Lung tumor lesions accessible from the alveolar side can be transfected, in principle, using gene vectors delivered as an aerosol. The cell surface marker CD49f (Integrin α6) is frequently upregulated in metastasizing, highly aggressive tumors. In this study, we utilize a CD49f binding peptide coupled to linear polyethylenimine (LPEI) promoting gene delivery into CD49f-overexpressing tumor cells in vitro and into lung lesions in vivo. We have synthesized a molecular conjugate based on LPEI covalently attached to the CD49f binding peptide CYESIKVAVS via a polyethylene glycol (PEG) spacer. Particles formed with plasmid DNA were small (<200 nm) and could be aerosolized without causing major aggregation or particle loss. In vitro, CD49f targeting significantly improved plasmid uptake and reporter gene expression on both human and murine tumor cell lines. For evaluation in vivo, localization and morphology of 4T1 murine triple-negative breast cancer tumor lesions in the lung of syngeneic BALB/c mice were identified by MRI. Polyplexes applied via intratracheal aerosolization were well tolerated and resulted in measurable transgene activity of the reporter gene firefly luciferase in tumor areas by bioluminescence imaging (BLI). Transfectability of tumors correlated with their accessibility for the aerosol. With CD49f-targeted polyplexes, luciferase activity was considerably increased and was restricted to the tumor area.

Power and Promise of Next-Generation Sequencing in Liquid Biopsies and Cancer Control

“…Immunotherapy is not equally effective for all types of tumors, and the efficacy varies from patient to patient. [73][74][75][76][77] The possible reasons are the heterogeneity of T cells and tumor cells and their complex interactions in the tumor microenvironment. [78][79][80][81] Immunogenomics is a relatively new field of cancer research.…”

Combined Chemisorption and Complexation Generate siRNA Nanocarriers with Biophysics Optimized for Efficient Gene Knockdown and Air–Blood Barrier Crossing

“… 62 However, in principle, targeted and PEGylated auropolyplexes might be applicable in lung cancer models based on our recent results where we could demonstrate accessibility of CD49f-overexpressing breast cancer lung metastases for gene transfection by peptide-targeted polyplexes via intratracheal administration due to the invasive growth of cancer cells. 63 …”

CD47-targeted cancer immunogene therapy: Secreted SIRPα-Fc fusion protein eradicates tumors by macrophage and NK cell activation

“…Polyplexes were generated with 10-kDa LPEI at an N/P ratio (molar ratio nitrogen in LPEI versus phosphate in pDNA) of 9 in principle as described previously. 50 Equal volumes of a pDNA-LPEI-containing solution were mixed by flash pipetting and incubated for 5 min at room temperature. For in vitro experiments, nanoparticles were generated at a final pDNA concentration of 20 μg/mL (of the desired plasmid) in HBS buffer (HEPES-buffered saline, 20 mM HEPES pH 7.4, 145 mM NaCl) and for in vivo experiments at 200 μg/mL in HBG buffer (HEPES-buffered glucose, 20 mM HEPES pH 7.4, 5% glucose w/v).…”